NCT07064421

Brief Summary

The goal of this observational study is to evaluate the effectiveness of Magnetoencephalography (MEG) in the preoperative assessment of children with refractory epilepsy, particularly in identifying the seizure focus, and to compare it with the gold standard methods of Stereo-electroencephalography (SEEG) and Electrocorticography (ECoG). The main questions this study aims to answer are:

  1. 1.How consistent is MEG with SEEG/ECoG in locating the epileptic focus in children with refractory epilepsy?
  2. 2.What is the clinical efficacy of MEG in identifying epileptic foci?
  3. 3.Be divided into 2 groups: the case group and the control group. Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment, while patients in the control group will undergo only SEEG/ECoG before surgery.
  4. 4.Be followed up at 1, 3, 6, and 12 months after surgery to assess seizure control, neurological function, and quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Nov 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Nov 2024Dec 2027

Study Start

First participant enrolled

November 5, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 14, 2025

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

3.2 years

First QC Date

February 26, 2025

Last Update Submit

July 3, 2025

Conditions

Keywords

EpilepsyMagnetoencephalography

Outcome Measures

Primary Outcomes (1)

  • Agreement in Epileptogenic Zone Localization Between Magnetoencephalography (MEG) and Stereoelectroencephalography/Electrocorticography (SEEG/ECoG) (Kappa Coefficient)

    This outcome measures the agreement between preoperative MEG and SEEG/ECoG (gold standard) in localizing the epileptogenic zone. Consistency will be quantified using Cohen's Kappa coefficient (κ) with 95% confidence intervals. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) will be calculated. Data aggregation will compare MEG-derived localization (categorized by brain regions, e.g., temporal lobe, frontal lobe) with intraoperative SEEG/ECoG findings. Statistical analysis will be performed using SPSS 27.0.

    From enrollment to 12 months after surgery.

Study Arms (2)

Case

Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment.

Diagnostic Test: Magnetoencephalography plus Stereo-electroencephalography/Electrocorticography

Control

Patients in the control group will undergo only SEEG/ECoG before surgery.

Diagnostic Test: Stereo-electroencephalography/Electrocorticography

Interventions

Use Magnetoencephalography and Stereo-electroencephalography/Electrocorticography in the preoperative assessment of children with drug-resistant epilepsy, particularly in identifying the seizure focus.

Case

Use Stereo-electroencephalography/Electrocorticography in the preoperative assessment of children with drug-resistant epilepsy, particularly in identifying the seizure focus.

Control

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients of Guangzhou Women and Children's Medical Center

You may qualify if:

  • Age range: 3-18 years old;
  • Clinically diagnosed with refractory epilepsy;
  • Capable of cooperating with magnetoencephalography evaluation and recording.

You may not qualify if:

  • Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
  • Patients using drugs that affect central nervous system function;
  • Patients who are not suitable for surgical procedures;
  • Patients with progressive neurological disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou Women and Children's medical center

Guangzhou, Guangdong, 511399, China

RECRUITING

MeSH Terms

Conditions

Epilepsy

Interventions

MagnetoencephalographyElectrocorticography

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMagnetometryInvestigative Techniques

Central Study Contacts

Ye Song, Medical Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2025

First Posted

July 14, 2025

Study Start

November 5, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations